Literature DB >> 12587180

The neurophysiological meaning of auditory P300 in subtypes of schizophrenia.

T J Müller1, P Kalus, W K Strik.   

Abstract

Event-related potentials are a powerful tool to investigate the real-time course of brain electrical mass activation during cognitive processing. In several psychiatric disorders, differences compared to healthy subjects have been reliably described. The specificity and the pathophysiological meaning of the findings were unclear in most studies, however. This review summarizes methodological aspects and findings, in healthy subjects and psychiatric patients, of investigations based on the auditory oddball paradigm, which evokes the P300 component of event-related potentials. Recent convergent results from P300 and brain imaging studies allowed the interpretation of P300 findings in psychotic disorders in terms of different specific and meaningful neurophysiological disturbances. Namely, core schizophrenia is characterized by a left-temporal dysfunction associated with deficits in verbal processing. Acute remitting schizophrenia-like psychoses (cycloid psychosis, ICD-10 F23), on the other hand, show normal hemispheric balance but consistent signs of cerebral hyperarousal. Recent studies further indicate that the drive for action of manic patients does not rely on over-excitation but rather on frontal disinhibition. The findings may help to further advance the understandings and sub-grouping of functional psychoses based on pathophysiological mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12587180     DOI: 10.3109/15622970109039979

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  5 in total

1.  SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit.

Authors:  J-P Terranova; C Chabot; M-C Barnouin; G Perrault; R Depoortere; G Griebel; B Scatton
Journal:  Psychopharmacology (Berl)       Date:  2005-04-14       Impact factor: 4.530

2.  Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study.

Authors:  HeeSeung Lee; Grace Y Wang; Louise E Curley; John J Sollers; Rob R Kydd; Ian J Kirk; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2015-12-03       Impact factor: 4.530

3.  Exploring the psychosis functional connectome: aberrant intrinsic networks in schizophrenia and bipolar disorder.

Authors:  Vince D Calhoun; Jing Sui; Kent Kiehl; Jessica Turner; Elena Allen; Godfrey Pearlson
Journal:  Front Psychiatry       Date:  2012-01-10       Impact factor: 4.157

4.  Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol.

Authors:  Lone Baandrup; Birgitte Fagerlund; Poul Jennum; Henrik Lublin; Jane L Hansen; Per Winkel; Christian Gluud; Bob Oranje; Birte Y Glenthoj
Journal:  BMC Psychiatry       Date:  2011-10-05       Impact factor: 3.630

5.  Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats.

Authors:  Agnès L Auclair; Alexandra Galinier; Joël Besnard; Adrian Newman-Tancredi; Ronan Depoortère
Journal:  Psychopharmacology (Berl)       Date:  2007-03-29       Impact factor: 4.415

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.